BioXcel Therapeutics (BTAI) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-6.04
-4.48
-2.91
-1.34

Details

Expected EPS
-1.34
Actual EPS
-2.18
Surprise EPS
-0.84
Surprise Percent
+62.69%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -2.18 per share for Q4 2025.

0 Comments

Share your thoughts